Potentiation of 5-hydroxytryptamine (5-HT) responses by a 5-HT uptake inhibitor in pulmonary and systemic vessels: Effects of exposing rats to hypoxia

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 368, Issue 6, 2003, Pages 520-527

  Wanstall, Janet C ^a   Fiore, Steven A ^a   Gambino, Agatha ^a   Chess Williams, Russell ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

5 Hydroxytryptamine; Citalopram; Hypoxia; Pulmonary hypertension; Pulmonary vasoconstriction; Serotonin transporter; SERT inhibitor

Indexed keywords

CITALOPRAM; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; ENDOTHELIUM; HEART RIGHT VENTRICLE PRESSURE; HEMATOCRIT; HEMODYNAMICS; HYPOXIA; LUNG BLOOD VESSEL; MALE; MESENTERIC ARTERY; NONHUMAN; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; SEROTONIN UPTAKE; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANOXIA; AORTA; CITALOPRAM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENDOTHELIUM, VASCULAR; HEMATOCRIT; MALE; MESENTERIC ARTERIES; PULMONARY ARTERY; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; VASOCONSTRICTION; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR PRESSURE;

EID: 0347361471     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0823-3     Document Type: Article

References (29)

1. Awabdy D, Bryan-Lluka LJ, Wanstall JC (2003) 5-Hydroxytryptamine and platelets: uptake and aggregation in hypoxic pulmonary hypertensive rats. Eur J Pharmacol 459:1-7
2. Doggrell SA, Wanstall JC, Gambino A (1999) Functional effects of 4-aminopyridine (4-AP) on pulmonary and systemic vessels from normoxic control and hypoxic pulmonary hypertensive rats. Naunyn-Schmiedeberg's Arch Pharmacol 360:317-323
3. Eddahibi S, Fabre V, Boni C, Martres MP, Raffestin B, Hamon M, Adnot S (1999) Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. Circ Res 84:329-336
4. Eddahibi S, Hanoun N, Lanfumey L, Lesch KP, Raffestin B, Hamon M, Adnot S (2000) Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest 105:1555-1562
5. Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, Simonneau G, Dartevelle P, Hamon M, Adnot, S (2001) Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 108:1141-1150
6. Fiore SA, Bryan-Lluka LJ, Wanstall JC (1998) Sensitisation to 5HT in pulmonary arteries from hypoxic rats: role of 5HT uptake (abstract). Proc Aust Soc Clin Exp Pharmacol Toxicol 5:136
7. Foster RW (1967) The potentiation of the responses to noradrenaline and isoprenaline of the guinea-pig isolated tracheal chain preparation by desipramine, cocaine, phentolamine, phenoxybenzamine, guanethidine, metanephrine and cooling. Br J Pharmacol Chemother 31:466-482
8. Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blashko H, Muscholl E (eds) Catecholamines (Handbook of Experimental Pharmacology series, Vol. 33). Springer, Berlin Heidelberg New York, pp 283-335
9. Gruetter CA, Lemke SM, Anestis DK, Szarek JL, Valentovic MA (1992) Potentiation of 5-hydroxytryptamine-induced contraction in rat aorta by chlorpheniramine, citalopram and fluoxetine. Eur J Pharmacol 217:109-118
10. Hampl V, Archer SL, Nelson DP, Weir EK (1993) Chronic ADRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure. J Appl Physiol 75:1748-1757
11. Hyttel J (1982) Citalopram - pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 6:277-295
12. Hyttel J (1994) Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 9 (Suppl. 1):19-26
13. Jeffery TK, Bryan-Lluka LJ, Wanstall JC (2000) Specific uptake of 5-hydroxytryptamine is reduced in lungs from hypoxic pulmonary hypertensive rats. Eur J Pharmacol 396:137-140
14. Jeffery TK, Wanstall JC (1999) Perindopril, an angiotensin converting enzyme inhibitor, in pulmonary hypertensive rats: comparative effects on pulmonary vascular structure and function. Br J Pharmacol 128:1407-1418
15. Jeffery TK, Wanstall JC (2001) Comparison of pulmonary vascular function and structure in early and established hypoxic pulmonary hypertension in rats. Can J Physiol Pharmacol 79:227-237
16. Lee SL, Wang WW, Moore BJ, Fanburg BL (1991) Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture. Circ Res 68:1362-1368
17. MacLean MR, Sweeney G, Baird M, McCulloch KM, Houslay M, Morecroft I (1996) 5-hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats. Br J Pharmacol 119:917-930
18. Marcos E, Adnot S, Pham MH, Nosjean A, Raffestin B, Hamon M, Eddahibi S (2003) Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension. Am J Respir Crit Care Med 168:487-493
19. Morita K, Ogawa Y, Tobise K (1996) Effect of endothelium on pulmonary artery vasoreactivity in monocrotaline-induced pulmonary hypertensive rats. Jpn Circ J 60:585-592
20. 2-adrenoceptors and potentiated by inhibitors of extraneuronal uptake. Br J Pharmacol 78:417-424
21. 1-adrenoceptor in the contractile response of rat pulmonary artery to 5-HT in the presence and absence of nitric oxide. Pulm Pharmacol Ther 13: 277-285
22. 3H uptake by pulmonary endothelial cells. J Cell Biol 54:456-467
23. Thomas BJ, Wanstall JC (2003) Alterations in pulmonary vascular function in rats exposed to intermittent hypoxia. Eur J Pharmacol 477:153-161
24. Trendelenburg U, Graefe K-H (1975) Supersensitivity to catecholamines after impairment of extraneuronal uptake or catechol-O-methyl transferase. Fed Proc 34:1971-1974
25. Villazon M, Padin JF, Cadavid MI, Enguix MJ, Tristan H, Orallo F, Loza MI (2002) Functional characterization of serotonin receptors in rat isolated aorta. Biol Pharm Bull 25:584-590
26. Wanstall JC, Hughes IE, O'Donnell SR (1992) Reduced relaxant potency of nitroprusside on pulmonary artery preparations taken from rats during the development of hypoxic pulmonary hypertension. Br J Pharmacol 107:407-413
27. Wanstall JC, Kaye JA, Gambino A (1997) The in vitro pulmonary vascular effects of FK409 (nitric oxide donor): a study in normotensive and pulmonary hypertensive rats. Br J Pharmacol 121:280-286
28. Wanstall JC, Gambino A, Chess-Williams R (2003) Influence of 5-hydroxytryptamine (5-HT) uptake on 5-HT potency in rat pulmonary and mesenteric arteries: effects of exposure of rats to hypoxia (abstract). Br J Pharmacol 138 (Suppl): 163P
29. Yu FS, Lee SL, Lanzillo JJ, Fanburg BL (1989) Endothelial cell inhibition of hypoxia-induced stimulation of serotonin uptake by vascular smooth muscle cells. Am Rev Respir Dis 139: 1144-1148